StockData
Curanex Pharmaceuticals Inc logo

Curanex Pharmaceuticals Inc (CURX) stock

CURXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$4.70+0.07 (+1.40%)

Close on Nov 17, 2026Market cap $7.37MP/E –Yield –

Curanex Pharmaceuticals enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Curanex Pharmaceuticals's enterprise value was $157.61M on Nov 11, 2026, against $270.41M a year earlier.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$157.61M-13.2%
2025Dec 31, 2025$181.59M–

More Curanex Pharmaceuticals figures

See a number that looks wrong?